Turkish pediatricians’ knowledge, attitudes, and awareness of respiratory syncytial virus (RSV) infection and immunization strategies: a cross-sectional study by İsmail Yıldız, Erdem Gönüllü, Sıla Yılmaz, Elvan Zengin, Osman Yeşilbaş, Ahmet Soysal

Subjects: Get full text

Knowledge, attitudes, and practices of Croatian pediatricians and pediatrics residents about RSV infection by Dina Mrcela, Shuyu Deng, You Li, Ivana Jukic, Josko Markic

Subjects: Get full text

Potential for Nirsevimab use in Pakistan by Muhammad Moaz, Basum Hayat

Subjects: “…Nirsevimab…”
Get full text

Prevention of respiratory syncytial virus infection in children. Recommendations of the Polish Society of Paediatrics and the National Paediatric Consultant by Teresa Jackowska, August Wrotek, Iwona Beń-Skowronek, Łukasz Dembiński, Tomasz Jarmoliński, Artur Mazur, Anna Medyńska, Katarzyna Plata-Nazar, Jan Styczyński, Tomasz Szczepański, Ewa Toporowska-Kowalska, Piotr Hartmann, Hanna Czajka, Jarosław Peregud-Pogorzelski

Subjects: Get full text

Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in FranceResearch in context by Charlotte Ocana de Sentuary, Clara Testard, Marion Lagrée, Maxime Leroy, Lisa Gasnier, Alicia Enes-Dias, Constance Leruste, Diariatou Diallo, Michael Génin, Thameur Rakza, François Dubos

Subjects: Get full text

Administration of Nirsevimab for RSV Prophylaxis in Infants: A Comprehensive Review by Pan-Pan Wu, Fang-Rui Ding

Subjects: Get full text

Development and Validation of a New Set of Primers for Identification of Circulating Lineages and Palivizumab/Nirsevimab Resistance in HRSV Isolates from Cabo Verde by María Paula Reyes-Zuluaga, José Antonio Pérez-Pérez, Wilson Correia, Isabel Inês M. de Pina Araújo, Emma Carmelo

Subjects: Get full text

Pediatric respiratory syncytial virus rehospitalization rate – a retrospective observational study from Switzerland by Naomi Rupp, Nina Schöbi, Andrea Duppenthaler, Carmen Casaulta, Matthias V Kopp, Philipp KA Agyeman, Christoph Aebi

Subjects: Get full text

Cost-effectiveness analysis of nirsevimab for prevention of respiratory syncytial virus disease among infants in Shanghai, China: A modeling study by Qiang Wang, Jiajin Wu, Lan Li, Zizhe Guo, Bo Zheng, Suyi Zhang, Cui Xiang, Meng Li, Xuefei Qiao, Xihong Lv, Weibing Wang

Subjects: “…Nirsevimab…”
Get full text

Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysisResearch in context by Amanda B. Payne, Steph Battan-Wraith, Elizabeth A.K. Rowley, Melissa S. Stockwell, Sara Y. Tartof, Kristin Dascomb, Stephanie A. Irving, Brian Dixon, Sarah W. Ball, Mark W. Tenforde, Gabriela Vazquez-Benitez, Ashley B. Stephens, Jungmi Han, Karthik Natarajan, S. Bianca Salas, Cassandra Bezi, Lina S. Sy, Bruno Lewin, Tamara Sheffield, Julie Arndorfer, Daniel Bride, Josh Van Otterloo, Allison L. Naleway, Padma D. Koppolu, Shaun Grannis, William Fadel, Colin Rogerson, Tom Duszynski, Sarah E. Reese, Patrick K. Mitchell, Sean Chickery, Heidi L. Moline, Morgan Najdowski, Allison Avrich Ciesla, Emily L. Reeves, Malini DeSilva, Katherine E. Fleming-Dutra, Ruth Link-Gelles

Subjects: Get full text

Nirsevimab prophylaxis on pediatric intensive care hospitalization for severe acute bronchiolitis: a clinical and economic analysis by Sarah Touati, Alexandre Debs, Luc Morin, Laure Jule, Caroline Claude, Pierre Tissieres, the PANDORA study group

Subjects: Get full text

Post-Marketing Surveillance of Nirsevimab: Safety Profile and Adverse Event Analysis from Spain’s 2023–2024 RSV Immunisation Campaign by Pablo Estrella-Porter, Elisa Correcher-Martínez, Alejandro Orrico-Sánchez, Juan José Carreras

Subjects: Get full text

Estimated impact of nirsevimab prophylaxis on the economic burden of respiratory syncytial virus disease in Northern Italy by Chryssoula Tzialla, Andrea Marcellusi, Lidia Decembrino, Stefano Ghirardello, Amelia Licari, GianLuigi Marseglia, Elena Tavella, Paolo Manzoni

Subjects: Get full text

Effectiveness of nirsevimab immunization against RSV infection in preterm infants: a systematic review and meta-analysis by Xiaopeng Wang, Xiaopeng Wang, Xiaopeng Wang, Li Kong, Li Kong, Li Kong, Xueou Liu, Panpan Wu, Panpan Wu, Panpan Wu, Lulu Zhang, Lulu Zhang, Lulu Zhang, Fangrui Ding, Fangrui Ding, Fangrui Ding

Subjects: Get full text

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases... by Denis Sauré, Miguel O’Ryan, Juan Pablo Torres, Natalia Trigo, Gonzalo Diaz, Marcel Goic, Charles Thraves, Jorge Pacheco, Patricio Aguilera, Andrea Caro, Leonardo J. Basso

Subjects: Get full text

Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain by Matilde Zornoza Moreno, Jaime Jesús Pérez Martín, Mª Cruz Gómez Moreno, Mª Pilar Ros Abellán

Subjects: “…Nirsevimab…”
Get full text

Implementation of the first respiratory syncytial (RSV) immunization campaign with nirsevimab in an autonomous community in Spain by Jaime Jesús Pérez Martín, Matilde Zornoza Moreno

Subjects: Get full text

Health economic evaluation of implementing a universal immunization program with nirsevimab compared to standard of care for the prevention of respiratory syncytial virus disease i... by Thomas Shin, Jason Kh Lee, Alexia Kieffer, Michael Greenberg, Jianhong Wu

Subjects: Get full text

Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysisResearch in context by Daira Trusinska, Bohee Lee, Sohail Ferdous, Harley H.Y. Kwok, Becky Gordon, Junyi Gao, Liantao Ma, Hanbiao Xiong, Sir Aziz Sheikh, Jürgen Schwarze, John Busby, Cheryl Gibbons, Simon B. Drysdale, Sir Lewis Ritchie, Thomas Williams, Ting Shi

Subjects: Get full text

Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody by Bryony Treston, Sarah Geoghegan

Subjects: Get full text